Managing Mandibular Osteoradionecrosis

Michael A Fritz1, Khashayar Arianpour1, Sara W Liu1

  • 1Division of Facial Plastic and Microvascular Surgery, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Summary

Mandibular osteoradionecrosis (MORN) management is shifting away from hyperbaric oxygen. New evidence supports pentoxifylline and tocopherol for early MORN, with advanced surgical options for later stages.